Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | KYMR | RGEN | ||
| Company | Protagonist Therapeutics Inc | Kymera Therapeutics Inc | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 101.13 | 79.46 | 110.90 | ||
| High | 101.76 | 79.98 | 112.59 | ||
| Low | 99.77 | 78.84 | 109.38 | ||
| Latest | 99.55 | 78.74 | 111.90 | ||
| Change | -1.33 | -1.91 | +0.16 | ||
| % Change | -1.32% | -2.37% | +0.14% | ||
| Volume | 35,519 | 36,228 | 54,799 | ||
| 20-Day Average Volume | 564,241 | 496,144 | 1,350,243 | ||
| Previous Close | 100.88 | 80.65 | 111.74 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 100.58 | 83.00 | 115.02 | ||
| 20-Day Raw Stochastic | 36.35% | 22.00% | 34.91% | ||
| 20-Day Relative Strength | 49.74 | 44.51 | 44.47 | ||
| Weighted Alpha | +84.81 | +65.50 | -15.97 | ||
| Today's Opinion | 56% Buy | 24% Buy | 100% Sell | ||
| Previous Opinion | 72% Buy | 40% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.21% since 05/14/26 | -5.75% since 05/14/26 | +8.00% since 05/14/26 | ||
| Low | 96.69 on 05/19/26 | 76.87 on 05/19/26 | 102.48 on 05/18/26 | ||
| High | 104.39 on 05/15/26 | 84.47 on 05/15/26 | 111.88 on 05/20/26 | ||
| 1-Month | |||||
| %Chg | -5.51% since 04/21/26 | -9.57% since 04/21/26 | -15.86% since 04/21/26 | ||
| Low | 96.69 on 05/19/26 | 76.87 on 05/19/26 | 100.99 on 05/14/26 | ||
| High | 107.00 on 04/22/26 | 90.10 on 04/22/26 | 134.94 on 04/22/26 | ||
| 3-Month | |||||
| %Chg | +20.90% since 02/20/26 | -8.88% since 02/20/26 | -17.71% since 02/20/26 | ||
| Low | 77.00 on 02/23/26 | 73.31 on 03/24/26 | 100.99 on 05/14/26 | ||
| High | 107.84 on 04/01/26 | 95.90 on 02/26/26 | 141.46 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | +17.16% since 11/21/25 | +20.59% since 11/21/25 | -31.30% since 11/21/25 | ||
| Low | 77.00 on 02/23/26 | 63.69 on 12/02/25 | 100.99 on 05/14/26 | ||
| High | 107.84 on 04/01/26 | 103.00 on 12/08/25 | 175.77 on 01/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,487,693 | 6,634,108 | 6,303,030 | ||
| Shares Outstanding, K | 64,311 | 82,258 | 56,408 | ||
| Annual Sales | 46,020,000 | 39,210,000 | 738,260,000 | ||
| Annual Net Income | -130,150,000 | -311,350,000 | 48,890,000 | ||
| Last Quarter Sales | 56,370,000 | 34,370,000 | 194,260,000 | ||
| Last Quarter Net Income | 3,780,000 | -69,230,000 | 8,330,000 | ||
| 60-Month Beta | 1.89 | 2.06 | 1.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 05/05/26 | -0.71 on 04/30/26 | 0.48 on 05/05/26 | ||
| Earnings Date | 08/05/26 | 08/10/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 60.29 | ||